Target intelligence / Profile preview

Reactive oxygen species–related pathways (ROS pathways) (ROS pathways)

Target
ROS pathways
Molecular classification
Signaling pathway, Metabolic pathway
01

Overview

Reactive oxygen species (ROS)–related pathways encompass the biochemical processes involved in the generation, signaling, and detoxification of oxygen-derived free radicals and non-radical oxidants (Pizzino et al., Oxid Med Cell Longev, 2017). These pathways include the enzymatic production of ROS by NADPH oxidases and the mitochondrial electron transport chain, balanced by antioxidant systems such as superoxide dismutase and the glutathione system (Sies et al., Nat Rev Mol Cell Biol, 2017). While physiological levels of ROS are essential for cell signaling and immune function, excessive ROS accumulation leads to oxidative stress and damage to cellular macromolecules (Frijhoff et al., Antioxid Redox Signal, 2015). This imbalance is a key driver in the progression of cancer, neurodegeneration, and cardiovascular diseases. Therapeutic strategies aim to restore redox homeostasis by either neutralizing ROS directly or modulating regulatory nodes like the Nrf2-KEAP1 pathway to induce protective gene expression (Tonelli et al., Antioxid Redox Signal, 2018; Robledinos-Antón et al., Antioxidants, 2019).

Other names
Oxidative stress pathwaysRedox signaling pathwaysROS signaling cascadesAntioxidant response pathways
02

Mechanism of action

Modulation of redox homeostasis through direct scavenging of reactive species, inhibition of ROS-generating enzymes like NADPH oxidase, or induction of endogenous antioxidant gene expression via the Nrf2/ARE pathway (Robledinos-Antón et al., Antioxidants, 2019).

03

Biological functions

Redox homeostasisSignal transductionCell deathOxidative stress responseImmune response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAging-related diseases
05

Safety considerations

Disruption of essential physiological ROS signaling in insulin and muscle pathways (Sies et al., Nat Rev Mol Cell Biol, 2017)Potential for pro-oxidant activity at high dosesLack of tissue specificity leading to systemic side effectsAntioxidant paradox where supplementation may increase mortality in certain populations (Pizzino et al., Oxid Med Cell Longev, 2017)
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)8-IsoprostaneGSH/GSSG ratioProtein carbonyls

Beyond the preview

Go deeper on Reactive oxygen species–related pathways (ROS pathways) (ROS pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species–related pathways (ROS pathways) (ROS pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call